Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
boston top stories
eli lilly
genentech
3
×
indiana blog main
3
×
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
abbvie
astrazeneca
avexis
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
celgene
clinical trials
detroit blog main
detroit top stories
fda
johnson & johnson
microbiome
national
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
What
fda
3
×
bio
drug
news
roundup
address
approval
approved
approves
august
biotech
blueprint
busy
cancer
carries
certain
companies
days
decisions
designed
devices
digital
disease
drugs
epidemic
fatty
frenzied
genetic
growing
known
latest
led
legacy
liver
medicines
merck
nash
nods
opioid
pass
Language
unset
Current search:
genentech
×
biotech
×
" boston blog main "
×
fda
×
" indiana blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More